Table 1. Population characteristics.
| Characteristics | All patients (n = 37) |
IDH1 wild-type tumors (n = 20) |
IDH1 mutant tumors (n = 17) |
P value |
|---|---|---|---|---|
| Age | 44.7 (36;53) | 49.1 (40–59) | 42.6 (36–45) | 0.04 |
| Female gender | 14 (37.8) | 8 (40) | 6 (35.3) | 0.77 |
| Delay between 18F-FET PET and histopathological diagnosis* | 1.1 (0.5;1.7) | 0.8 (0.2–1.3) | 1.4 (1.0–2.1) | 0.49 |
| Treatments | ||||
| Surgery | 6 (16.2) | 1 (5) | 5 (29.4) | 0.05 |
| Radiochemotherapy | 11 (29.7) | 10 (50) | 1 (5.9) | 0.003 |
| Chemotherapy | 9 (24.3) | 4 (20) | 5 (29.4) | 0.51 |
| Surgery + radiochemotherapy | 8 (21.6) | 3 (15) | 5 (29.4) | 0.65 |
| None | 3 (8.1) | 2 (10) | 1 (5.9) | 0.29 |
Values are median (25th-75th interquartile range) or n (%).
*expressed as months
IDH, isocitrate dehydrogenase